MediWound Ltd. (MDWD)Healthcare | Biotechnology | Yavne, Israel | NasdaqGM
14.25 USD
-0.04
(-0.280%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:42 a.m. EDT
MediWound presents a stark case of a distressed biotech asset where the market has priced out the business entirely. The company is hemorrhaging cash, with operating and free cash flows deeply negative, while revenue has contracted by nearly 63% year-over-year. The balance sheet is fragile, with debt-to-equity nearing 20x and no meaningful cash reserves to sustain operations without further capital raises. Although insiders have recently purchased shares, likely due to the depressed valuation rather than a turnaround in fundamentals, the operational reality remains dire. The stock trades at a significant discount to its 200-day average, reflecting a consensus view that the current trajectory is unsustainable. With no dividend to provide income and a multi-year decline in earnings and sales, there is no margin of safety here; the investment thesis relies entirely on a speculative catalyst that has not yet materialized. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.147505 |
| AutoETS | 0.147920 |
| MSTL | 0.149162 |
| AutoARIMA | 0.174416 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 4.47 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.069 |
| Excess Kurtosis | -1.11 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 19.617 |
| Revenue per Share | 1.217 |
| Market Cap | 183,144,640 |
| Forward P/E | -6.42 |
| Beta | 0.15 |
| Profit Margins | -180.30% |
| Website | https://www.mediwound.com |
As of July 11, 2026, 5:42 a.m. EDT: Speculators are positioning defensively with heavy put volume relative to calls, particularly in the September and December expirations where out-of-the-money puts dominate open interest. Call activity is sparse and concentrated at lower strikes, suggesting a lack of aggressive bullish conviction despite the stock trading near its 52-week lows.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3019052 |
| Address1 | 42 Hayarkon Street |
| All Time High | 135.17 |
| All Time Low | 7.1 |
| Ask | 18.17 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 99,960 |
| Average Daily Volume3 Month | 86,998 |
| Average Volume | 86,998 |
| Average Volume10Days | 99,960 |
| Beta | 0.145 |
| Bid | 10.16 |
| Bid Size | 2 |
| Book Value | 3.218 |
| City | Yavne |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.25 |
| Current Ratio | 2.41 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 14.42 |
| Day Low | 14.0 |
| Debt To Equity | 19.617 |
| Display Name | MediWound |
| Earnings Call Timestamp End | 1,779,885,000 |
| Earnings Call Timestamp Start | 1,779,885,000 |
| Earnings Timestamp | 1,779,885,000 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda | -27,015,000 |
| Ebitda Margins | -1.8658099 |
| Enterprise To Ebitda | -5.439 |
| Enterprise To Revenue | 10.148 |
| Enterprise Value | 146,935,376 |
| Eps Current Year | -2.385 |
| Eps Forward | -2.22 |
| Eps Trailing Twelve Months | -2.26 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 15.2642 |
| Fifty Day Average Change | -1.0142002 |
| Fifty Day Average Change Percent | -0.06644306 |
| Fifty Two Week Change Percent | -30.190521 |
| Fifty Two Week High | 21.11 |
| Fifty Two Week High Change | -6.8600006 |
| Fifty Two Week High Change Percent | -0.3249645 |
| Fifty Two Week Low | 13.54 |
| Fifty Two Week Low Change | 0.71000004 |
| Fifty Two Week Low Change Percent | 0.052437227 |
| Fifty Two Week Range | 13.54 - 21.11 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,395,322,200,000 |
| Float Shares | 8,829,160 |
| Forward Eps | -2.22 |
| Forward P E | -6.4189186 |
| Free Cashflow | -18,442,750 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 121 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.19608 |
| Gross Profits | 2,839,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15855 |
| Held Percent Institutions | 0.5846 |
| Implied Shares Outstanding | 12,852,255 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,671,494,400 |
| Last Split Factor | 1:7 |
| Long Business Summary | MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. |
| Long Name | MediWound Ltd. |
| Market | us_market |
| Market Cap | 183,144,640 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1570881 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -26,105,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 182,887,588 |
| Number Of Analyst Opinions | 6 |
| Open | 14.27 |
| Operating Cashflow | -18,765,000 |
| Operating Margins | -5.41017 |
| Payout Ratio | 0.0 |
| Phone | 972 7 797 14100 |
| Previous Close | 14.29 |
| Price Eps Current Year | -5.974843 |
| Price Hint | 2 |
| Price To Book | 4.4282165 |
| Price To Sales Trailing12 Months | 12.648984 |
| Profit Margins | -1.80296 |
| Quick Ratio | 2.19 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.04 |
| Regular Market Change Percent | -0.279916 |
| Regular Market Day High | 14.42 |
| Regular Market Day Low | 14.0 |
| Regular Market Day Range | 14.0 - 14.42 |
| Regular Market Open | 14.27 |
| Regular Market Previous Close | 14.29 |
| Regular Market Price | 14.25 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 72,622 |
| Return On Assets | -0.23507999 |
| Return On Equity | -0.71821 |
| Revenue Growth | -0.627 |
| Revenue Per Share | 1.217 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 12,852,255 |
| Shares Percent Shares Out | 0.1269 |
| Shares Short | 1,630,683 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,626,813 |
| Short Name | MediWound Ltd. |
| Short Percent Of Float | 0.145 |
| Short Ratio | 16.51 |
| Source Interval | 15 |
| Symbol | MDWD |
| Target High Price | 36.0 |
| Target Low Price | 22.0 |
| Target Mean Price | 30.16667 |
| Target Median Price | 31.0 |
| Total Cash | 44,646,000 |
| Total Cash Per Share | 3.468 |
| Total Debt | 8,126,000 |
| Total Revenue | 14,479,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.26 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 17.129074 |
| Two Hundred Day Average Change | -2.879074 |
| Two Hundred Day Average Change Percent | -0.16808113 |
| Type Disp | Equity |
| Volume | 72,622 |
| Website | https://www.mediwound.com |
| Zip | 8,122,745 |